{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:05:42Z","timestamp":1792623942158,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,12,4]],"date-time":"2011-12-04T00:00:00Z","timestamp":1322956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s11136-011-0077-3","type":"journal-article","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T19:05:24Z","timestamp":1322939124000},"page":"1519-1525","source":"Crossref","is-referenced-by-count":82,"title":["Diagnostic delay, quality of life and patient satisfaction among women diagnosed with endometrial or ovarian cancer: a nationwide Danish study"],"prefix":"10.1007","volume":"21","author":[{"given":"Kirstine M.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Bang","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bent","family":"Ottesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Krasnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,4]]},"reference":[{"key":"77_CR1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJM199609193351213","volume":"335","author":"D Blumenthal","year":"1996","unstructured":"Blumenthal, D. (1996). Part 1: Quality of care\u2014What is it? New England Journal of Medicine, 335, 891\u2013894.","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 2","key":"77_CR2","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1038\/sj.bjc.6605384","volume":"101","author":"RD Neal","year":"2009","unstructured":"Neal, R. D. (2009). Do diagnostic delays in cancer matter? Brit. J. Cancer, 101(Suppl 2), S9\u2013S12.","journal-title":"Brit. J. Cancer"},{"key":"77_CR3","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(99)02143-1","volume":"353","author":"MA Richards","year":"1999","unstructured":"Richards, M. A., Westcombe, A. M., Love, S. B., Littlejohns, P., & Ramirez, A. J. (1999). Influence of delay on survival in patients with breast cancer: A systematic review. Lancet, 353, 1119\u20131126.","journal-title":"Lancet"},{"key":"77_CR4","first-page":"212","volume":"57","author":"RD Neal","year":"2007","unstructured":"Neal, R. D., Allgar, V. L., Ali, N., Leese, B., Heywood, P., Proctor, G., et al. (2007). Stage, survival and delays in lung, colorectal, prostate and ovarian cancer: comparison between diagnostic routes. British Journal of General Practice, 57, 212\u2013219.","journal-title":"British Journal of General Practice"},{"key":"77_CR5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/bmj.325.7357.196","volume":"325","author":"SC Crawford","year":"2002","unstructured":"Crawford, S. C., Davis, J. A., Siddiqui, N. A., de Caestecker, L., Gillis, C. R., Hole, D., et al. (2002). The waiting time paradox: Population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ, 325, 196.","journal-title":"BMJ"},{"key":"77_CR6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1463-1318.2006.00958.x","volume":"8","author":"KS Rupassara","year":"2006","unstructured":"Rupassara, K. S., Ponnusamy, S., Withanage, N., & Milewski, P. J. (2006). A paradox explained? Patients with delayed diagnosis of symptomatic colorectal cancer have good prognosis. Colorectal Dis, 8, 423\u2013429.","journal-title":"Colorectal Dis"},{"key":"77_CR7","first-page":"S550","volume":"8","author":"CE Schwartz","year":"2002","unstructured":"Schwartz, C. E., & Sprangers, M. A. (2002). An introduction to quality of life assessment in oncology: The value of measuring patient-reported outcomes. American Journal of Managed Care, 8, S550\u2013S559.","journal-title":"American Journal of Managed Care"},{"key":"77_CR8","first-page":"29","volume":"4","author":"DF Cella","year":"1990","unstructured":"Cella, D. F., & Tulsky, D. S. (1990). Measuring quality of life today: Methodological aspects. Oncology (Williston Park), 4, 29\u201338.","journal-title":"Oncology (Williston Park)"},{"key":"77_CR9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.surg.2009.03.019","volume":"146","author":"A Chow","year":"2009","unstructured":"Chow, A., Mayer, E. K., Darzi, A. W., & Athanasiou, T. (2009). Patient-reported outcome measures: The importance of patient satisfaction in surgery. Surgery, 146, 435\u2013443.","journal-title":"Surgery"},{"key":"77_CR10","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0959-8049(97)00049-X","volume":"33","author":"A Coates","year":"1997","unstructured":"Coates, A., Porzsolt, F., & Osoba, D. (1997). Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. European Journal of Cancer, 33, 1025\u20131030.","journal-title":"European Journal of Cancer"},{"key":"77_CR11","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0959-8049(02)00098-9","volume":"38","author":"NR Maisey","year":"2002","unstructured":"Maisey, N. R., Norman, A., Watson, M., Allen, M. J., Hill, M. E., & Cunningham, D. (2002). Baseline quality of life predicts survival in patients with advanced colorectal cancer. European Journal of Cancer, 38, 1351\u20131357.","journal-title":"European Journal of Cancer"},{"key":"77_CR12","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1200\/JCO.2007.13.3439","volume":"26","author":"CC Gotay","year":"2008","unstructured":"Gotay, C. C., Kawamoto, C. T., Bottomley, A., & Efficace, F. (2008). The prognostic significance of patient-reported outcomes in cancer clinical trials. Journal of Clinical Oncology, 26, 1355\u20131363.","journal-title":"Journal of Clinical Oncology"},{"key":"77_CR13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/00016340902971482","volume":"88","author":"KM Robinson","year":"2009","unstructured":"Robinson, K. M., Ottesen, B., Christensen, K. B., & Krasnik, A. (2009). Diagnostic delay experienced among gynecological cancer patients: A nationwide survey in Denmark. Acta Obstetricia et Gynecologica Scandinavica, 88, 685\u2013692.","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"77_CR14","unstructured":"The Danish Cancer Society. (2006) A cancer patients world."},{"key":"77_CR15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365\u2013376.","journal-title":"Journal of the National Cancer Institute"},{"key":"77_CR16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","volume":"70","author":"JL Benedet","year":"2000","unstructured":"Benedet, J. L., Bender, H., Jones, H., I. I. I., Ngan, H. Y., & Pecorelli, S. (2000). FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology. International Journal of Gynaecology & Obstetrics, 70, 209\u2013262.","journal-title":"International Journal of Gynaecology & Obstetrics"},{"key":"77_CR17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/jwh.2009.1410","volume":"19","author":"A Thind","year":"2010","unstructured":"Thind, A., Hoq, L., Diamant, A., & Maly, R. C. (2010). Satisfaction with care among low-income women with breast cancer. Journal of Womens Health (Larchmt), 19, 77\u201386.","journal-title":"Journal of Womens Health (Larchmt)"},{"key":"77_CR18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1477-7525-7-102","volume":"7","author":"A Montazeri","year":"2009","unstructured":"Montazeri, A. (2009). Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health and Quality of Life Outcomes, 7, 102.","journal-title":"Health and Quality of Life Outcomes"},{"key":"77_CR19","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1002\/ijc.25642","volume":"128","author":"E Greimel","year":"2011","unstructured":"Greimel, E., Daghofer, F., & Petru, E. (2011). Prospective assessment of quality of life in long-term ovarian cancer survivors. International Journal of Cancer, 128, 3005\u20133011.","journal-title":"International Journal of Cancer"},{"key":"77_CR20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ygyno.2007.08.088","volume":"108","author":"MS Carey","year":"2008","unstructured":"Carey, M. S., Bacon, M., Tu, D., Butler, L., Bezjak, A., & Stuart, G. C. (2008). The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Gynecologic Oncology, 108, 100\u2013105.","journal-title":"Gynecologic Oncology"},{"key":"77_CR21","first-page":"98","volume":"6","author":"D Gupta","year":"2008","unstructured":"Gupta, D., Grutsch, J. F., & Lis, C. G. (2008). Patient satisfaction with quality of life as a prognostic indicator in ovarian cancer patients treated in an integrative treatment setting. Journal of the Society for Integrative Oncology, 6, 98\u2013104.","journal-title":"Journal of the Society for Integrative Oncology"},{"key":"77_CR22","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1200\/JCO.2004.08.080","volume":"22","author":"A Bezjak","year":"2004","unstructured":"Bezjak, A., Tu, D., Bacon, M., Osoba, D., Zee, B., Stuart, G., et al. (2004). Quality of life in ovarian cancer patients: Comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study. Journal of Clinical Oncology, 22, 4595\u20134603.","journal-title":"Journal of Clinical Oncology"},{"key":"77_CR23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0895-4356(96)00428-3","volume":"50","author":"M Groenvold","year":"1997","unstructured":"Groenvold, M., Klee, M. C., Sprangers, M. A., & Aaronson, N. K. (1997). Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. Journal of Clinical Epidemiology, 50, 441\u2013450.","journal-title":"Journal of Clinical Epidemiology"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-011-0077-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11136-011-0077-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-011-0077-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T04:00:20Z","timestamp":1559361620000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11136-011-0077-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,4]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["77"],"URL":"https:\/\/doi.org\/10.1007\/s11136-011-0077-3","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,4]]}}}